Cai Jing Wang·2025-09-26 04:17Core Viewpoint - The company emphasizes its commitment to clinical value and long-term strategy in cutting-edge fields such as brain-computer interfaces and rehabilitation robots, focusing on the maturity of technology and commercial viability [1] Group 1: Strategic Focus - The company is advancing clinical explorations and collaborations based on the maturity of technology and business synergy, given the high technical barriers and strict regulatory requirements in the medical industry [1] - The company aims to continuously communicate its strategic path focused on the entire industry chain of tumor pre-diagnosis and treatment through regular reports, announcements, and investor engagement activities [1] Group 2: Future Plans - The company plans to leverage resources from the Haier ecosystem to steadily enhance its core capabilities while actively seeking frontier collaboration opportunities that align with its strategy [1] - Management will continue to optimize team structure and broadly recruit professional talent to drive high-quality development of the company [1]